🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Pirtobrutinib

Pirtobrutinib and Mosunetuzumab for the Treatment of Relapsed/Refractory Grades 1-3A Follicular Lymphoma, PROMOTE-FL Trial NCT06948786Phase 21 site📍 Seattle University of Washington · Tests: Pirtobrutinib, Mosunetuzumab, Biospecimen Collection, Biopsy Procedure, Computed Tomography Implanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase Inhibitors NCT05643235NA1 site📍 New Hyde Park Northwell Health · Tests: Medtronic LINQ-2 Insertable Cardiac Monitor (ILR) A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma NCT06588478Phase 2131 sites📍 Chandler📍 Duarte📍 Irvine Loxo Oncology, Inc. · Tests: Pirtobrutinib Pirtobrutinib for the Treatment of Elderly Patients With Chronic Lymphocytic Leukemia NCT07685717Phase 21 site📍 Columbus Jennifer Woyach · Tests: Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography, Electronic Health Record Review Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT) NCT05536349Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Pirtobrutinib, Obinutuzumab, Venetoclax, Valacyclovir, Allopurinol Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib NCT07428707EARLY Phase 11 site📍 Bethesda National Heart, Lung, and Blood Institute (NHLBI) · Tests: Pirtobrutinib R-PMDT Regimen in Newly Diagnosed PCNSL NCT07604987Phase 21 site📍 Tianjin Zou Dehui · Tests: R-PMDT A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib NCT06876649Phase 438 sites📍 Jacksonville📍 Miami📍 Sarasota Eli Lilly and Company · Tests: Pirtobrutinib Phase II Study of Pirtobrutinib, Rituximab (PR) in Previously Untreated Low and Intermediate Risk MCL (Mantle Cell Lymphoma) Patients NCT06263491Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Rituximab, Pirtobrutinib A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma NCT06973187Phase 3217 sites📍 Birmingham📍 Phoenix📍 Irvine BeOne Medicines · Tests: Tacabrutideg, Pirtobrutinib Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) Patients NCT05529069Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Pirtobrutinib, Venetoclax Thiotepa in Combination With Pirtobrutinib (a BTK Inhibitor) and Sintilimab (a PD-1 Inhibitor) for Frail or Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma NCT07416890Phase 21 site📍 Hangzhou Zhejiang Cancer Hospital · Tests: Thiotepa, Pirtobrutinib , Sintilimab(TPS) A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) NCT05254743Phase 3143 sites📍 Anaheim📍 Cerritos📍 Palo Alto Loxo Oncology, Inc. · Tests: Pirtobrutinib, Ibrutinib Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL NCT07516093Phase 36 sites📍 Macon📍 Fort Wayne📍 Indianapolis Nurix Therapeutics, Inc. · Tests: NX-5948, Pirtobrutinib A Phase 2 Trial of GlOfitamab anD pIrtobrutinib in Mantle Cell Lymphoma Patients With Prior BTK Inhibitor Exposure. NCT05833763Phase 22 sites📍 Parkville📍 Nedlands Australasian Leukaemia and Lymphoma Group · Tests: Glofitamab, Pirtobrutinib, Obinutuzumab, Tocilizumab Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation NCT06043674Phase 25 sites📍 Atlanta📍 Boston📍 Boston Christine Ryan · Tests: Glofitamab, Obinutuzumab, Polatuzumab Vedotin, Atezolizumab, Tocilizumab A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma NCT07218341Phase 450 sites📍 Mobile📍 Tucson📍 Jacksonville Eli Lilly and Company · Tests: Pirtobrutinib, Idelalisib Pirtobrutinib (LOXO-305) and Venetoclax for the Treatment of Patients With CLL or SLL Resistant to Covalent BTKi NCT06466122Phase 21 site📍 Columbus Kerry Rogers · Tests: Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography, Pirtobrutinib LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies NCT05990465Phase 11 site📍 Milwaukee Medical College of Wisconsin · Tests: Pirtobrutinib, LV20.19 CAR T cells Clinical Trial to Evaluate the Efficacy and Safety of Pirtobrutinib With Rituximab in Patients With Mantle Cell Lymphoma NCT07285590Phase 216 sites📍 Lisbon📍 Lisbon📍 Badalona Grupo Español de Linfomas y Transplante Autólogo de Médula … · Tests: Pirtobrutinib and rituximab Adding Pirtobrutinib to the Usual Treatment for People With Newly Diagnosed Richter Transformation, The PIRAMID Trial NCT07220187Phase 362 sites📍 Irvine📍 Laguna Hills📍 Orange SWOG Cancer Research Network · Tests: Biospecimen Collection, Computed Tomography, Cyclophosphamide, Doxorubicin Hydrochloride, Echocardiography Test A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL) NCT07231952Phase 29 sites📍 Boston📍 Boston📍 Basking Ridge Memorial Sloan Kettering Cancer Center · Tests: Pirtobrutinib, Venetoclax, Rituximab A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma NCT06876662Phase 436 sites📍 Miami📍 Sarasota📍 Atlanta Eli Lilly and Company · Tests: Pirtobrutinib Glofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma NCT06252675Phase 24 sites📍 Davis📍 Los Angeles📍 San Diego University of California, San Francisco · Tests: Obinutuzumab, Glofitamab, Pirtobrutinib, Tumor Imaging, Biospecimen Collection A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia NCT06721013Phase 1, Phase 243 sites📍 Los Angeles📍 Palo Alto📍 Washington D.C. Eli Lilly and Company · Tests: Pirtobrutinib, Placebo ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL NCT07342478Phase 36 sites📍 Skokie📍 Bethesda📍 Las Vegas Newave Pharmaceutical Inc · Tests: Rocbrutinib, Pirtobrutinib Pirtobrutinib, Lisaftoclax, and Rituximab in the Treatment of R/R DLBCL NCT07255963Phase 21 site📍 Suzhou The First Affiliated Hospital of Soochow University · Tests: Pirtobrutinib, Lisaftoclax, Rituximab A Multicenter, Prospective Clinical Trial With a Concurrent Control Evaluating Methotrexate Combined With Rituximab,Sintilimab and Pirtobrutinib vs. Investigator-Selected Standard of Care in Treatment-Naive PCNSL NCT07350850Phase 24 sites📍 Xiamen📍 Wuhan📍 Changchun Tongji Hospital · Tests: Pirtobrutinib, Sintilimab, Rituximab, Methotrexate, Standard of Care (Investigator Selected) Phase 2 Open Label Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in R/R MCL NCT06553872Phase 23 sites📍 Stanford📍 Miami📍 Tampa H. Lee Moffitt Cancer Center and Research Institute · Tests: Pirtobrutinib, Brexucabtagene Autoleucel Pirtobrutinib in Combination With Rituximab in Adults With Untreated Marginal Zone Lymphoma (PIONEER-MZL) NCT06390956Phase 22 sites📍 St Louis📍 Salt Lake City University of Utah · Tests: Pirtobrutinib, Rituximab
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy